Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for July 16th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 16th:

CoreLogic, Inc. (CLGX - Free Report) : This property information, insight, analytics, and data-enabled solutions provider has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10% over the last 60 days.

CoreLogic's shares gained 41.3% over the last one month compared with the S&P 500’s growth of 5.2%. The company possesses a Momentum Score of A.

Sonic Automotive, Inc. (SAH - Free Report) : This automotive retailer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Sonic Automotive’s shares gained nearly 34% over the last one month. The company possesses a Momentum Score of A.

TFI International Inc. (TFII - Free Report) : This transportation and logistics services provider has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.4% over the last 60 days.

TFI International’s shares gained 19.6% over the last one month. The company possesses a Momentum Score of A.

Maxim Integrated Products, Inc. (MXIM - Free Report) : This company that designs, develops, manufactures, and markets a range of linear and mixed-signal integrated circuits has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.4% over the last 60 days.

Maxim's shares gained 20.9% over the last one month. The company possesses a Momentum Score of B.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>